Supriya Lifescience Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

570.37

460.94

530.05

385.37

311.64

Operating profit

172.98

128.90

213.98

167.30

98.64

Interest

2.11

3.08

4.20

4.08

6.13

Gross profit

181.50

135.30

217.36

174.07

102.79

EPS (Rs)

14.80

11.16

18.86

16.89

9.86

Other income

10.64

9.49

7.58

10.86

10.28

Stock adjustment

30.31

-6.51

-3.03

-12.44

-

Raw material

191.43

187.32

198.83

140.57

152.38

Power and fuel

-

-

-

-

-

Employee expenses

67.64

55.58

49.08

32.76

25.66

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

108.02

95.65

71.18

57.18

34.96

Provisions made

-

-

-

-

-

Depreciation

15.81

11.82

10.12

6.76

6.05

Taxation

46.58

33.63

55.44

43.72

24.59

Net profit / loss

119.11

89.86

151.81

123.59

72.16

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

16.10

16.10

16.10

14.64

14.64

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

30.33

27.96

40.37

43.41

31.65

GPM (%)

31.24

28.76

40.43

43.93

31.93

NPM (%)

20.50

19.10

28.24

31.19

22.41